Status:

COMPLETED

Effectiveness and Cost-effectiveness of the Energetic Program

Lead Sponsor:

Radboud University Medical Center

Collaborating Sponsors:

ZonMw: The Netherlands Organisation for Health Research and Development

Revalidatiefonds Nederland

Conditions:

Neuromuscular Diseases

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

Fatigue is present in at least 60% of the patients with a muscle disease and can be the most disabling symptom. In combination with other impairments, this often results in low levels of physical acti...

Eligibility Criteria

Inclusion

  • formal diagnosis of muscular disease, either FascioScapuloHumeral Dystrophy (FSHD), Inclusion Body Myositis (IBM), Mitochondrial Myopathy (MM) or any other;
  • being severely fatigued
  • being cardiopulmonary stable and capable of aerobic training (as determined using a submaximal cycling exercise test with ECG (electrocardiography) and advice from a consultant cardiologist and pulmonologist);
  • being motivated, committed to the program, and 'ready to change' which is discussed with the patient during the screening by a rehabilitation physician and an occupational therapist; to this end, motivational interviewing will be used (including a advantages/disadvantages matrix; a visual analogue scale (VAS) to rate the importance of participation in de program; and a VAS to rate the confidence a patient has that participation in the program is feasible)
  • being able to formulate at least 3 individual participation goals during the interview with the occupational therapist.

Exclusion

  • active depression or other psychiatric disorder as indicated by a consultant psychologist or by the medical history,
  • pregnancy,
  • severe co-morbid condition,
  • having participated in the Energetic program before
  • a travel distance perceived as too burdensome

Key Trial Info

Start Date :

August 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2017

Estimated Enrollment :

53 Patients enrolled

Trial Details

Trial ID

NCT02208687

Start Date

August 1 2014

End Date

May 1 2017

Last Update

November 7 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Radboudumc

Nijmegen, Gelderland, Netherlands